Literature DB >> 34281673

Relation of the Number of Cardiovascular Conditions and Short-term Symptom Improvement After Percutaneous Coronary Intervention for Stable Angina Pectoris.

Christopher R Flynn1, Ariela R Orkaby2, Linda R Valsdottir3, Daniel B Kramer3, Kalon K Ho4, John A Dodson5, Robert W Yeh3, Jordan B Strom6.   

Abstract

With aging of the population, cardiovascular conditions (CC) are increasingly common in individuals undergoing PCI for stable angina pectoris (AP). It is unknown if the overall burden of CCs associates with diminished symptom improvement after PCI for stable AP. We prospectively administered validated surveys assessing AP, dyspnea, and depression to patients undergoing PCI for stable AP at our institution, 2016-2018. The association of CC burden and symptoms at 30-days post-PCI was assessed via linear mixed effects models. Included individuals (N = 121; mean age 68 ± 10 years; response rate = 42%) were similar to non-included individuals. At baseline, greater CC burden was associated with worse dyspnea, depression, and physical limitations due to AP, but not AP frequency or quality of life. PCI was associated with small improvements in AP and dyspnea (p ≤ 0.001 for both), but not depression (p = 0.15). After multivariable adjustment, including for baseline symptoms, CC burden was associated with a greater improvement in AP physical limitations (p = 0.01) and depression (p = 0.002), albeit small, but not other symptom domains (all p ≥ 0.05). In patients undergoing PCI for stable AP, increasing CC burden was associated with worse dyspnea, depression, and AP physical limitations at baseline. An increasing number of CCs was associated with greater improvements, though small, in AP physical limitations and depression. In conclusion, the overall number of cardiovascular conditions should not be used to exclude patients from PCI for stable AP on the basis of an expectation of less symptom improvement.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34281673      PMCID: PMC8384702          DOI: 10.1016/j.amjcard.2021.06.007

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   3.133


  23 in total

1.  Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention.

Authors:  Stephen W Waldo; Eric A Secemsky; Cashel O'Brien; Kevin F Kennedy; Eugene Pomerantsev; Thoralf M Sundt; Edward J McNulty; Benjamin M Scirica; Robert W Yeh
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Keeping the patient in view: defining the appropriateness of percutaneous coronary interventions.

Authors:  Jeptha P Curtis; Harlan M Krumholz
Journal:  Circulation       Date:  2004-12-21       Impact factor: 29.690

3.  Patient-Reported Outcomes in Cardiology.

Authors:  Daniel M Blumenthal; Jordan B Strom; Linda R Valsdottir; Sydney E Howard; Neil W Wagle; Kalon K L Ho; Daniel M Horn; Sandra M O'Keefe; Jason H Wasfy; Joshua P Metlay; Robert W Yeh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-11

4.  Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina.

Authors:  S J Pocock; R A Henderson; T Clayton; G H Lyman; D A Chamberlain
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

5.  Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study.

Authors:  Ali Shafiq; Suzanne V Arnold; Kensey Gosch; Faraz Kureshi; Tracie Breeding; Philip G Jones; John Beltrame; John A Spertus
Journal:  Am Heart J       Date:  2016-02-27       Impact factor: 4.749

6.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

7.  Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease.

Authors:  J A Spertus; J A Winder; T A Dewhurst; R A Deyo; J Prodzinski; M McDonell; S D Fihn
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

8.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

Authors:  Rasha Al-Lamee; David Thompson; Hakim-Moulay Dehbi; Sayan Sen; Kare Tang; John Davies; Thomas Keeble; Michael Mielewczik; Raffi Kaprielian; Iqbal S Malik; Sukhjinder S Nijjer; Ricardo Petraco; Christopher Cook; Yousif Ahmad; James Howard; Christopher Baker; Andrew Sharp; Robert Gerber; Suneel Talwar; Ravi Assomull; Jamil Mayet; Roland Wensel; David Collier; Matthew Shun-Shin; Simon A Thom; Justin E Davies; Darrel P Francis
Journal:  Lancet       Date:  2017-11-02       Impact factor: 79.321

9.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

Review 10.  The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.

Authors:  Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Abraham Flaxman; Christopher J L Murray; Mohsen Naghavi
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.